Hong Kong to surpass Nasdaq as king of biotech listings in ...
文章推薦指數: 80 %
The quest builds on Li's listing reforms in April 2018 that opened the door for such companies, including drugs developers to sell shares to the ... TheHKEXhasattractedaslewofChinese-backedbiotechnologylistingsthisyear.Photo:ReutersLinkCopiedPostTheHKEXhasattractedaslewofChi
延伸文章資訊
- 1Hong Kong IPO Guide for Biotech Companies | Ashurst
Under the new regime, pre-revenue Biotech Companies may become eligible to list under Chapter 18A...
- 2Hong Kong Biotech IPOs since Listing ... - PharmaBoardroom
Ascletis Pharma · Beigene (listed on NASDAQ in 2016) · Hua Medicine · Innovent Biologics · Junshi...
- 3Bio-tech Listings on HKEX - Stephenson Harwood
risks in Mainland China's biotech companies. On the other hand, Mainland China's investors can bu...
- 4Hong Kong to surpass Nasdaq as king of biotech listings in ...
The quest builds on Li's listing reforms in April 2018 that opened the door for such companies, i...
- 5Listing on the Hong Kong Stock Exchange Main Board A ...
Listing Requirements Highlights for Biotech Companies. With effect from 30 April 2018, Biotech Co...